[go: up one dir, main page]

WO2017218922A3 - Compositions and methods for the treatment of bacterial infections - Google Patents

Compositions and methods for the treatment of bacterial infections Download PDF

Info

Publication number
WO2017218922A3
WO2017218922A3 PCT/US2017/037924 US2017037924W WO2017218922A3 WO 2017218922 A3 WO2017218922 A3 WO 2017218922A3 US 2017037924 W US2017037924 W US 2017037924W WO 2017218922 A3 WO2017218922 A3 WO 2017218922A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
bacterial infections
compositions
methods
gram
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2017/037924
Other languages
French (fr)
Other versions
WO2017218922A2 (en
WO2017218922A8 (en
Inventor
James M. Balkovec
Daniel C. BENSEN
Timothy Blizzard
Allen Borchardt
Thomas P. Brady
Zhi-yong CHEN
Quyen-Quyen Thuy Do
Wanlong Jiang
Thanh Lam
Jeffrey B. Locke
Alain Noncovich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cidara Therapeutics Inc
Original Assignee
Cidara Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cidara Therapeutics Inc filed Critical Cidara Therapeutics Inc
Publication of WO2017218922A2 publication Critical patent/WO2017218922A2/en
Publication of WO2017218922A3 publication Critical patent/WO2017218922A3/en
Publication of WO2017218922A8 publication Critical patent/WO2017218922A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compositions and methods for the treatment of bacterial infections include compounds containing dimers of cyclic heptapeptides. In particular, compounds can be used in the treatment of bacterial infections caused by Gram-negative bacteria.
PCT/US2017/037924 2016-06-17 2017-06-16 Compositions and methods for the treatment of bacterial infections Ceased WO2017218922A2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201662351537P 2016-06-17 2016-06-17
US62/351,537 2016-06-17
US201662397045P 2016-09-20 2016-09-20
US62/397,045 2016-09-20
US201662434268P 2016-12-14 2016-12-14
US62/434,268 2016-12-14

Publications (3)

Publication Number Publication Date
WO2017218922A2 WO2017218922A2 (en) 2017-12-21
WO2017218922A3 true WO2017218922A3 (en) 2018-01-25
WO2017218922A8 WO2017218922A8 (en) 2018-03-01

Family

ID=60664378

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/037924 Ceased WO2017218922A2 (en) 2016-06-17 2017-06-16 Compositions and methods for the treatment of bacterial infections

Country Status (1)

Country Link
WO (1) WO2017218922A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7041166B2 (en) * 2017-04-05 2022-03-23 カーザ グローバル，リミティド ライアビリティ カンパニー Compositions and Methods Containing Triaryl Polyamines
CN108329225B (en) * 2018-01-24 2021-03-09 北京大学 A kind of terephthaloyl dimer derivative and its synthesis method and application
WO2020014469A1 (en) * 2018-07-11 2020-01-16 Cidara Therapeutics, Inc. Compositions and methods for the treatment of bacterial infectons
CN111060606A (en) * 2018-09-29 2020-04-24 湖南九典制药股份有限公司 Method for detecting dirithromycin related substances
WO2020150275A1 (en) * 2019-01-14 2020-07-23 New York University Cyclic peptide dimers
CN111909047B (en) * 2020-08-20 2023-01-31 苏州亚科科技股份有限公司 Preparation process of 2- [ (2-amino-2-oxyethyl) - (carboxymethyl) amino ] acetic acid
WO2025072713A1 (en) 2023-09-27 2025-04-03 Judo Bio, Inc. Polymyxins for delivery of agents to the kidney

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380356B1 (en) * 1999-12-07 2002-04-30 Advanced Medicine, Inc. Multivalent polymyxin antibiotics
US7807637B2 (en) * 2006-08-11 2010-10-05 Northern Antibiotics Oy Polymyxin derivatives and uses thereof
US8937040B2 (en) * 2008-12-23 2015-01-20 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380356B1 (en) * 1999-12-07 2002-04-30 Advanced Medicine, Inc. Multivalent polymyxin antibiotics
US7807637B2 (en) * 2006-08-11 2010-10-05 Northern Antibiotics Oy Polymyxin derivatives and uses thereof
US8937040B2 (en) * 2008-12-23 2015-01-20 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE Pubchem 20 September 2010 (2010-09-20), Database accession no. 46883548 *

Also Published As

Publication number Publication date
WO2017218922A2 (en) 2017-12-21
WO2017218922A8 (en) 2018-03-01

Similar Documents

Publication Publication Date Title
WO2017218922A8 (en) Compositions and methods for the treatment of bacterial infections
WO2017017631A3 (en) Antibacterial therapeutics and prophylactics
MX2016015218A (en) Macrocyclic broad spectrum antibiotics.
WO2013184755A3 (en) Seca inhibitors and methods of making and using thereof
PH12019500360A1 (en) Antibiotic compounds
EA201691766A1 (en) ORGANIC COMPOUNDS, MONOBACTAMA, FOR THE TREATMENT OF BACTERIAL INFECTIONS
WO2015003816A3 (en) Cystobactamides
WO2015114666A3 (en) Treatments for resistant acne
EP4477272A3 (en) Polymyxin derivatives as antimicrobial compounds
WO2017083431A3 (en) Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
WO2015110969A3 (en) Nitrogen containing compounds and their use as antibacterial agents
WO2018128826A8 (en) Compositions and methods for the treatment of bacterial infections
AU2015352440B2 (en) Compounds
WO2016004513A8 (en) Anti-bacterial pyruvate kinase modulator compounds, compositions, uses and methods
MX2018006190A (en) ANTIBIOTICS OF LARGE MACROCICLICAL SPECTRUM.
EP4268897A3 (en) Minocycline compounds for biodefense
PH12018500358A1 (en) Compounds for use in an antibacterial applications
HK1243951A1 (en) Antimicrobial combinations and their use in the treatment of microbial infection
WO2015024021A3 (en) Antibacterial compounds
WO2020014501A8 (en) Compositions and methods for the treatment of bacterial infections
PH12016501532A1 (en) Antibacterial combinations comprising polymyxin
WO2017002049A3 (en) Conserved chaperone domain for type vi secretion system
WO2019126353A3 (en) Compositions and methods for the treatment of bacterial infections
MX382439B (en) Carbapenem compounds
MA39955A (en) Disinfectant and antimicrobial compositions, in particular for the veterinary field

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17814191

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17814191

Country of ref document: EP

Kind code of ref document: A2